Evaluation of multi-dimensional intelligent management in improving compliance of subcutaneous specific immunotherapy in children

• Published in: Xīn yīxué Vol. 53; no. 2; pp. 98 - 103
• Main Author: Yang Lifen, Zhang Pingping, Pan Li, Shi Xin, Li Yating, Wen Yanming, Yuan Yufang, Chen Zhuanggui, Zhong Xinqi
• Format: Journal Article
• Language: Chinese
• Published: Editorial Office of Journal of New Medicine 01.02.2022
• Subjects: subcutaneous specific immunotherapy|multi-dimensional intelligent management|children|treatment compliance|allergic rhinitis|allergic asthma
• ISSN: 0253-9802
• DOI: 10.3969/j.issn.0253-9802.2022.02.005

Objective To evaluate the effect of multi-dimensional intelligent management on improving the compliance of subcutaneous specific immunotherapy （SCIT） in children. Methods 162 children diagnosed with allergic rhinitis（AR）and（or） allergic asthma（AS） receiving SCIT were recruited in this study.85 children received routine management combined with multi-dimensional intelligent management were assigned into the intelligent group and 77 children received routine management were allocated into the control group. The SCIT shedding rate in the initial treatment stage and the time taken to reach the maintenance phase were compared between two groups. The clinical efficacy of SCIT in children was assessed by the symptom score for AR,AS symptom scores （daytime and nighttime）, visual analogue scale （VAS） score and medication score were compared between two groups. The improvement of the scores of each scale from the beginning of SCIT to the maintenance treatment was evaluated and compared between two groups. The degree o